Preclinical News and Research

RSS
IGF1 drug improves nerve cell communication in PMS mouse model

IGF1 drug improves nerve cell communication in PMS mouse model

Cancer Institute of New Jersey investigators target autophagy

Cancer Institute of New Jersey investigators target autophagy

Researchers identify drug that improves communication between nerve cells in Phelan-McDermid Syndrome

Researchers identify drug that improves communication between nerve cells in Phelan-McDermid Syndrome

New research seeks customised treatment of cardiovascular diseases

New research seeks customised treatment of cardiovascular diseases

Results of BioSante's 2A/Furin technology in industrial antibody CHO expression system announced

Results of BioSante's 2A/Furin technology in industrial antibody CHO expression system announced

Data from three Phase II clinical trials of PS-targeting antibody to be presented at 2010 ASCO Annual Meeting

Data from three Phase II clinical trials of PS-targeting antibody to be presented at 2010 ASCO Annual Meeting

Toxcure granted U.S. patent for method of treating neoplasms with neurotoxins

Toxcure granted U.S. patent for method of treating neoplasms with neurotoxins

Onyx Pharmaceuticals announces presentations evaluating carfilzomib for multiple myeloma at 46th ASCO

Onyx Pharmaceuticals announces presentations evaluating carfilzomib for multiple myeloma at 46th ASCO

Narrow-band imaging could be novel tool for in vivo assessment of mucosal angiogenesis

Narrow-band imaging could be novel tool for in vivo assessment of mucosal angiogenesis

AMT reports positive preclinical data from cholesterol targeting AAV gene therapy study

AMT reports positive preclinical data from cholesterol targeting AAV gene therapy study

TAP to unveil innovative RAFT system at TERMIS Conference

TAP to unveil innovative RAFT system at TERMIS Conference

BioLife Solutions first-quarter revenue up 36% to $513,000

BioLife Solutions first-quarter revenue up 36% to $513,000

NeuroTherapeutics Pharma closes $43 million Series B financing round

NeuroTherapeutics Pharma closes $43 million Series B financing round

Study shows plexiform lesion develops in experimental rat model of severe PAH

Study shows plexiform lesion develops in experimental rat model of severe PAH

Scientists present data on denufosol tetrasodium for CF at ATS 2010 International Conference

Scientists present data on denufosol tetrasodium for CF at ATS 2010 International Conference

Inviragen initiates first clinical trial of DENVax vaccine to protect against dengue fever

Inviragen initiates first clinical trial of DENVax vaccine to protect against dengue fever

Phase I study of SNS-032 demonstrates safety, potential clinical activity in treating B-cell malignancies

Phase I study of SNS-032 demonstrates safety, potential clinical activity in treating B-cell malignancies

Oncolytics Biotech initiates Phase I study of REOLYSIN and FOLFIRI in colorectal cancer patients

Oncolytics Biotech initiates Phase I study of REOLYSIN and FOLFIRI in colorectal cancer patients

Discovery Labs revalidates optimized BAT in program to gain FDA approval of Surfaxin for RDS

Discovery Labs revalidates optimized BAT in program to gain FDA approval of Surfaxin for RDS

Cell Therapeutics reports cardiac safety results from phase II trial of pixantrone in CHOP-R regimen

Cell Therapeutics reports cardiac safety results from phase II trial of pixantrone in CHOP-R regimen

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.